News and Features

The FDA and CDC greenlight updated COVID-19; prescription drug for dry eye disease now available; head-to-head study compares Skyrizi to Stelara for Crohn disease; the REMS program has been updated for IBS treatment Lotronex; and the FDA cracks down on companies selling unnaproved eye products.


With fall on the horizon, MPR sat down with Dr Abdul-Mutakabbir, PharmD, MPH, Assistant Professor of Clinical Pharmacy at the University of California San Diego to discuss the new COVID-19, flu and RSV vaccines, vaccine hesitancy, health equity and representation in medicine.